HER-2/ neu Gene Amplification in Esophageal Adenocarcinoma and Its Influence on Survival
作者： Sarah K. Thompson , Thomas R. Sullivan , Ruth Davies , Andrew R. Ruszkiewicz
DOI: 10.1245/S10434-011-1554-1
关键词: Esophagectomy 、 Survival rate 、 Adenocarcinoma 、 Medicine 、 Cancer 、 Oncology 、 Internal medicine 、 Incidence (epidemiology) 、 Surgical oncology 、 Prospective cohort study 、 Gene duplication
摘要: Background HER-2/neu (c-erbB-2, HER2) gene amplification and protein overexpression have been associated with poor prognosis in several solid tumors, including breast gastric cancer. Its incidence significance esophageal adenocarcinoma is unknown.
springer.com
core.ac.uk
sci-hub.se 参考文章(37)
Arnulf H. Hoelscher, Elfriede Bollschweiler, Nadia Harbec, Karen Becker, J. Ruediger Siewert, Tsutomu Nakamura, Hjalmar Nekarda, Prognostic value of DNA ploidy and cerbB‐2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus Cancer. ,vol. 73, pp. 1785- 1794 ,(1994) , 10.1002/1097-0142(19940401)73:7<1785::AID-CNCR2820730703>3.0.CO;2-0
A D Graham, D Faratian, F Rae, J St J Thomas, Tissue microarray technology in the routine assessment of HER‐2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization Histopathology. ,vol. 52, pp. 847- 855 ,(2008) , 10.1111/J.1365-2559.2008.03047.X
Glenn D. Francis, Mark A. Jones, Geoffrey F. Beadle, Sandra R. Stein, Bright-field in situ hybridization for HER2 gene amplification in breast cancer using tissue microarrays: correlation between chromogenic (CISH) and automated silver-enhanced (SISH) methods with patient outcome. Diagnostic Molecular Pathology. ,vol. 18, pp. 88- 95 ,(2009) , 10.1097/PDM.0B013E31816F6374
Francis G. Duhaylongsod, Marcia R. Gottfried, J. Dirk Iglehart, Anna L. Vaughn, Walter G. Wolfe, The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus. Annals of Surgery. ,vol. 221, pp. 677- 684 ,(1995) , 10.1097/00000658-199506000-00007
Thomas P. Brien, Robert D. Odze, Christine E. Sheehan, Barbara J. McKenna, Jeffrey S. Ross, HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma Human Pathology. ,vol. 31, pp. 35- 39 ,(2000) , 10.1016/S0046-8177(00)80195-1
M Hofmann, O Stoss, D Shi, R Büttner, M van de Vijver, W Kim, A Ochiai, J Rüschoff, T Henkel, Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology. ,vol. 52, pp. 797- 805 ,(2008) , 10.1111/J.1365-2559.2008.03028.X
Sarah K. Thompson, Andrew R. Ruszkiewicz, Glyn G. Jamieson, Adrian Esterman, David I. Watson, Bas P. L. Wijnhoven, Peter J. Lamb, Peter G. Devitt, Improving the Accuracy of TNM Staging in Esophageal Cancer: A Pathological Review of Resected Specimens Annals of Surgical Oncology. ,vol. 15, pp. 3447- 3458 ,(2008) , 10.1245/S10434-008-0155-0
J Jankowski, G Coghill, D Hopwood, K G Wormsley, Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus. Gut. ,vol. 33, pp. 1033- 1038 ,(1992) , 10.1136/GUT.33.8.1033
L Gibault, J-P Metges, V Conan-Charlet, P Lozac'h, M Robaszkiewicz, C Bessaguet, N Lagarde, A Volant, Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer British Journal of Cancer. ,vol. 93, pp. 107- 115 ,(2005) , 10.1038/SJ.BJC.6602625
Uta Reichelt, Peer Duesedau, Maria Ch Tsourlakis, Alexander Quaas, Björn C Link, Paulus G Schurr, Jussuf T Kaifi, Stephanie J Gros, Emre F Yekebas, Andreas Marx, Ronald Simon, Jakob R Izbicki, Guido Sauter, Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus. Modern Pathology. ,vol. 20, pp. 120- 129 ,(2007) , 10.1038/MODPATHOL.3800712